Source:http://linkedlifedata.com/resource/pubmed/id/19652917
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2009-12-17
|
pubmed:abstractText |
The T:G mismatch specific DNA glycosylase (TDG) is known as an important enzyme in repairing damaged DNA. Recent studies also showed that TDG interacts with a p160 protein, steroid receptor coactivator 1 or nuclear receptor coactivator 1 (SRC1), and is involved in transcriptional activation of the estrogen receptor. However, whether other members of the p160 family are also involved in TDG-interaction and signal transduction regulation remains to be seen. In this study, we employed the mammalian two-hybrid system to investigate the interaction between TDG and another member of the p160 family, nuclear receptor coactivator 3 (NCoA-3). We found that a DXXD motif from aa 294-297 within TDG was responsible for the TDG-NCoA-3 interaction, we also found that a LLXXXL motif (X means any amino acid) from aa 1029-1037 (LLRNSL) and a merged LLXXL motif (LLDQLHTLL) from aa 1053-1061 in NCoA-3 were important for the TDG-NCoA-3 interactions. Mutation of the two aspartic acids (aa 294 and 297) into two alanines in TDG significantly affected the interaction and subsequent transcriptional activation of several steroid hormone receptors including, estrogen-, androgen- and progesterone- receptors in Huh7 cells. We also identified that mutations of NCoA-3 at either leucines 1029-1030 or 1053-1054 (replaced by alanines) also reduced the interaction activity between TDG and NCoA1. These data indicated that the TDG-NCoA-3 interaction is important for broad range activation of steroid hormone nuclear receptors, and may also contribute significantly to further understanding of TDG-related nuclear receptor regulation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1573-4919
|
pubmed:author |
pubmed-author:BrusnykCraigC,
pubmed-author:BurchTanyaT,
pubmed-author:CaoJingxinJ,
pubmed-author:ChiangShirleyS,
pubmed-author:CuttsToddT,
pubmed-author:DickKevinK,
pubmed-author:EdwardsMegan RaeMR,
pubmed-author:HeRuntaoR,
pubmed-author:LiXuguangX,
pubmed-author:PiperJessicaJ,
pubmed-author:RadziwonAlinaA,
pubmed-author:Van DomselaarGaryG
|
pubmed:issnType |
Electronic
|
pubmed:volume |
333
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
221-32
|
pubmed:meshHeading |
pubmed-meshheading:19652917-Amino Acid Motifs,
pubmed-meshheading:19652917-Cell Line, Tumor,
pubmed-meshheading:19652917-Humans,
pubmed-meshheading:19652917-Mutagenesis, Site-Directed,
pubmed-meshheading:19652917-Nuclear Receptor Coactivator 3,
pubmed-meshheading:19652917-Protein Interaction Mapping,
pubmed-meshheading:19652917-Receptors, Cytoplasmic and Nuclear,
pubmed-meshheading:19652917-Thymine DNA Glycosylase,
pubmed-meshheading:19652917-Transcriptional Activation,
pubmed-meshheading:19652917-Two-Hybrid System Techniques
|
pubmed:year |
2010
|
pubmed:articleTitle |
The interaction between thymine DNA glycosylase and nuclear receptor coactivator 3 is required for the transcriptional activation of nuclear hormone receptors.
|
pubmed:affiliation |
National Microbiology Laboratory, Health Canada, 1015 Arlington St, Winnipeg, MB, R3E 3R2, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|